Shares of Aurora Cannabis Inc. ACB slid 6.41% to $4.02 Friday, on what proved to be an all-around grim trading session for ...

Aurora Cannabis Inc., together with its subsidiaries ... and consumption in the form of oil, capsules, dried flowers, vapes, dried milled strains, edibles, concentrates, and strain specific ...

Aurora discovered a new source of genetic resistance against powdery mildew, a pathogen, in cannabis sativa. Given this discovery, the company is set to develop powdery mildew-resistant plants.

The stock's rise snapped a three-day losing streak.

Aurora Cannabis CEO Miguel Martin thinks the cannabis industry and its investors are too focused on US recreational consumers and are missing a more profitable opportunity: medical marijuana.

Cannabis stocks Aurora Cannabis Inc. (NASDAQ ... Street typically use earnings growth and fundamental research as a form of valuation and forecasting. But many in trading turn to technical ...

Aurora Cannabis (ACB) is pleased to announce the company’s discovery of a novel source of genetic resistance against powdery mildew, PM2, that ...

Aurora Cannabis gained more than 25% following the ... Street typically use earnings growth and fundamental research as a form of valuation and forecasting. But many in trading turn to technical ...

Aurora Cannabis Inc., together with its subsidiaries ... and consumption in the form of oil, capsules, dried flowers, vapes, dried milled strains, edibles, concentrates, and strain specific ...

EDMONTON, AB, March 20, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's ...